ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Hew Finally Okays New NIH Study Section For Chemical, Environmental Carcinogenesis

March 16, 1979

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

NCAB Calls For Modification Of Rules For NIH Scientist-Industry Collaboration

December 10, 2010

Researcher Falsified EMF Data, ORI Says

July 30, 1999

Senate Emphasizes Balance In NCI’s Research Programs

September 24, 1993